Accelerate Biotech Patient Recruitment with Smarter Site Selection, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how early-phase biotech teams can improve enrollment predictability by integrating recruitment with feasibility and site selection. The featured speakers will discuss how patient populations, investigator experience, referral networks and protocol requirements can inform stronger site decisions. Attendees will also explore how recruitment data can identify where patients are being lost, support faster course correction and help align enrollment with key development milestones.

TORONTO, Nov. 3, 2026 /PRNewswire/ -- Early-phase clinical trials operate under compressed timelines, complex protocols, narrow eligibility criteria and limited patient populations, making even small delays disproportionately costly. For emerging biotech companies, where lean teams and critical development milestones heighten execution risk, traditional approaches to site feasibility and recruitment planning may no longer be sufficient. This webinar will explore how sponsors and CROs can improve enrollment predictability by integrating recruitment earlier into study design, protocol development, feasibility and site selection.

Evidence-based feasibility can reduce reliance on historical site performance and questionnaire-driven projections by incorporating recruitable patient populations, investigator experience, prior trial performance, startup timelines, competing studies, referral networks, infrastructure and protocol-specific capabilities. The featured speakers will discuss the unique considerations and requirements that distinguish early-phase site selection from later-phase studies.

The session will also examine the patient recruitment funnel and sources of attrition that occur well before enrollment. From diagnosis and referral through awareness, pre-screening, testing, consent, screening, enrollment and ongoing participation, each step can reduce the pool of recruitable patients. Protocol burden, eligibility requirements, travel, biomarker testing, physician referral barriers, perceptions of benefit-risk and competing care or trial options can all influence participation. Direct site and investigator insights can help identify these barriers and assess how well a protocol aligns with patients seen in clinical practice.

Attendees will learn how to optimize for enrollment velocity rather than site count, use real-time operational signals to course-correct and establish predefined triggers for intervention. This webinar will explore how recruitment intelligence can identify why referrals are not converting, where patients are being lost and when intervention is needed. Connecting more predictable early-phase execution to safety and PK readouts, dose-escalation decisions, expansion planning, financing milestones and partnering strategy can help reduce uncertainty across the development timeline.

Register for this webinar to learn how patient recruitment can be integrated with feasibility and site selection to improve enrollment predictability in early-phase clinical trials.

Join experts from the PPD clinical research business of Thermo Fisher Scientific, Chris Morris, Senior Director, Strategy & Insights, Patient First Digital Solutions; Irina Strachkova, Senior Patient Recruitment & Engagement Lead (PREL), Patient First Digital Solutions; and Dr. Lukasz Wiech, MD, MBA, Director Site Operations, Trialmed, for the live webinar on Tuesday, November 17, 2026, at 11am EST (5pm CET / EU-Central).

For more information, or to register for this event, visit Accelerate Biotech Patient Recruitment with Smarter Site Selection.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: skumar@xtalks.com

SOURCE Xtalks